Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Angelini

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Tumori|May 27, 2026
Hospice admission of cancer patients receiving disease-modifying therapies near the end of life: implications for eligibility criteriaCarla Bettini, Andrea Carlini, Laura Fabbri, et al.
Medical Oncology (Northwood, London, England)|June 6, 2022
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)Isacco Desideri, Sara Lucidi, Giulio Francolini, et al.
Therapeutic Advances in Drug Safety|April 29, 2026
The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patientsStefania Crucitta, Paola Cinacchi, Irene Bargagna, et al.
Breast (Edinburgh, Scotland)|October 25, 2022
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclibMarzia Del Re, Stefania Crucitta, Claudia Omarini, et al.
Cancers|September 27, 2025
Older Age Does Not Predict Inadequate Pain Management in Cancer Patients: A Multicenter Prospective Analysis from Italian Radiotherapy Departments (ARISE-Study)Costanza M Donati, Erika Galietta, Francesco Cellini, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Tumori|May 27, 2026
Hospice admission of cancer patients receiving disease-modifying therapies near the end of life: implications for eligibility criteriaCarla Bettini, Andrea Carlini, Laura Fabbri, et al.
Medical Oncology (Northwood, London, England)|June 6, 2022
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833)Isacco Desideri, Sara Lucidi, Giulio Francolini, et al.
Therapeutic Advances in Drug Safety|April 29, 2026
The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patientsStefania Crucitta, Paola Cinacchi, Irene Bargagna, et al.
Breast (Edinburgh, Scotland)|October 25, 2022
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclibMarzia Del Re, Stefania Crucitta, Claudia Omarini, et al.
Cancers|September 27, 2025
Older Age Does Not Predict Inadequate Pain Management in Cancer Patients: A Multicenter Prospective Analysis from Italian Radiotherapy Departments (ARISE-Study)Costanza M Donati, Erika Galietta, Francesco Cellini, et al.
Pageof 3